US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

0.9922

-0.0178-1.76%

Post-market: 0.9775-0.0147-1.48%19:48 EDT

Volume:283.25K

Turnover:279.88K

Market Cap:182.46M

PE:-14.17

High:1.01

Open:0.9984

Low:0.9717

Close:1.01

Loading ...

Overview Company News Filings

BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence Collaboration

Tevogen Bio announces AI collaboration with Microsoft

Tevogen Bio Holdings: Proactively Investigating Potential Treatments for Human Papillomavirus

THOMSON REUTERS

Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure

THOMSON REUTERS

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

Tevogen files for additional patent on predictive AI

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

Tevogen announces additional responsibilities for key leaders

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

THOMSON REUTERS

Press Release: Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data

MT Newswires Live

Tevogen Bio Surges Premarket After Reporting Q3 Results, 'Nearly All' Liabilities Eliminated

MT Newswires Live

Tevogen reports Q3 EPS (3c) vs (3c) last year

Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year

BRIEF-Tevogen Bio Reports Third Quarter 2024 Financial

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

THOMSON REUTERS

Press Release: Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Tevogen Bio Delays Latest Quarterly Filing with SEC

Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TVGN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":0.9922,"timestamp":1745611200000,"preClose":1.01,"halted":0,"volume":283248,"hourTrading":{"tag":"盘后","latestPrice":0.9775,"preClose":0.9922,"latestTime":"19:48 EDT","volume":4270,"amount":4225.3759,"timestamp":1745624890261},"delay":0,"floatShares":22757419,"shares":183893433,"eps":-0.070045,"marketStatus":"Market Closed","change":-0.0178,"latestTime":"04-25 16:00:00 EDT","open":0.9984,"high":1.0053,"low":0.9717,"amount":279879.54113952,"amplitude":0.033267,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.070045,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.01,"preHourTrading":{"tag":"盘前","latestPrice":0.9997,"preClose":1.01,"latestTime":"09:29 EDT","volume":8173,"amount":8237.4808835,"timestamp":1745587770614},"postHourTrading":{"tag":"盘后","latestPrice":0.9775,"preClose":0.9922,"latestTime":"19:48 EDT","volume":4270,"amount":4225.3759,"timestamp":1745624890261},"volumeRatio":0.8628464969096111},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":22757419,"roa":"-746.67%","roe":"--","lyrEps":-0.070045,"volumeRatio":0.8628464969096111,"shares":183893433,"dividePrice":0,"high":1.0053,"amplitude":0.033267,"preClose":1.01,"low":0.9717,"week52Low":0.2556,"pbRate":"-11.79","week52High":3.09,"institutionHeld":0,"latestPrice":0.9922,"eps":-0.070045,"divideRate":0,"volume":283248,"delay":0,"ttmEps":-0.070045,"open":0.9984,"prevYearClose":1.03,"prevWeekClose":0.9796,"prevMonthClose":1.08,"prevQuarterClose":1.08,"fiveDayClose":0.9796,"twentyDayClose":1.2,"sixtyDayClose":1.45},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506113598","title":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506113598","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506113598?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:46","pubTimestamp":1737758774,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence CollaborationJan 24 (Reuters) - Microsoft Corp MSFT.O:TEVOGEN BIO BROADENS RELATIONSHIP WITH MICROSOFT TO DEEPE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU2023250330.USD","SG9999002224.SGD","LU1778281490.HKD","LU2362540622.SGD","TVGNW","LU0823434583.USD","LU0784384876.USD","LU0889565833.HKD","LU1988902786.USD","LU2237957811.SGD","TVGN","LU2592432038.USD","LU0690374961.EUR","LU0289739343.SGD","LU0095938881.EUR","LU0353189763.USD","LU1244550577.SGD","LU1267930573.SGD","LU1697837992.HKD","LU0689626769.HKD","SGXZ81514606.USD","LU0347712357.USD","LU2065171311.SGD","LU2111349929.HKD","LU1868836591.USD","LU1691799644.USD","LU1935042215.USD","LU0187121727.USD","LU2210149790.SGD","LU0310800379.SGD","LU0868494617.USD","IE0004445015.USD","BK4548","LU2506952097.USD","LU1642822529.SGD","LU2764262908.HKD","LU0157215616.USD","LU0080751232.USD","LU0057025933.USD","BK4525","IE00B4YYXB79.USD","IE00BJTD4N35.SGD","LU2237443382.USD","LU2361045086.USD","LU0426412945.USD","LU1868837136.USD","LU1934455863.HKD","MSFT","LU0792757196.USD"],"gpt_icon":1},{"id":"2506811444","title":"Tevogen Bio announces AI collaboration with Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506811444","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506811444?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:40","pubTimestamp":1737758413,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. (TVGN) announced that it has broadened its relationship with Microsoft (MSFT) to broaden its AI-focused collaboration and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361044865.SGD","LU2106854487.HKD","LU0823417653.USD","MSFT","IE0004091025.USD","LU1988902786.USD","LU0642271901.SGD","LU0784385840.USD","LU2506951875.HKD","SG9999014575.USD","LU1334329650.SGD","SG9999014542.SGD","LU2592432038.USD","LU0310800379.SGD","BK4503","LU2023250330.USD","LU0960925559.SGD","LU1548497426.USD","LU2237443382.USD","IE0034235303.USD","GB00BDT5M118.USD","TVGN","LU2362541513.USD","LU0784383803.USD","LU1066051811.HKD","LU1244550577.SGD","LU1823568750.SGD","LU0965508806.USD","LU2237957811.SGD","BK4534","LU0265550359.USD","LU2236285917.USD","LU1037948541.HKD","LU1236620750.USD","LU1046421795.USD","LU1366192091.USD","IE00BZ1G4Q59.USD","LU0171293334.USD","LU0323239441.USD","LU1934455194.USD","IE00B4JS1V06.HKD","LU2250418816.HKD","LU2213496289.HKD","IE00BMPRXR70.SGD","LU0029864427.USD","SG9999014880.SGD","BK4504","LU1066051498.USD","LU2237957902.USD","LU0784384876.USD"],"gpt_icon":0},{"id":"2506819471","title":"Tevogen Bio Holdings: Proactively Investigating Potential Treatments for Human Papillomavirus","url":"https://stock-news.laohu8.com/highlight/detail?id=2506819471","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506819471?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BN29S564.USD","LU1582986433.USD","LU1037948541.HKD","LU1691799644.USD","LU2357305700.SGD","IE00BDRTCR15.USD","LU0994945656.USD","IE00B1BXHZ80.USD","IE00B775H168.HKD","LU1868836914.USD","LU0289961442.SGD","IE00BK4W5L77.USD","LU0868494617.USD","LU0820562030.AUD","LU0894486033.HKD","LU2242650005.HKD","LU0820561909.HKD","IE00BJTD4V19.USD","LU1066051811.HKD","LU0187121727.USD","LU0690374615.EUR","LU0965509010.AUD","LU1571399168.USD","TVGN","IE00BJJMRX11.SGD","LU0081259029.USD","LU1629891620.HKD","LU0149725797.USD","LU0162691827.USD","LU1323610961.USD","LU1839511570.USD","LU0069063385.USD","LU1564329115.USD","IE00BJJMRY28.SGD","LU1340139317.AUD","LU0690374961.EUR","LU1823568750.SGD","LU2552382132.HKD","LU0882574139.USD","LU1670628061.USD","SG9999014575.USD","IE00B3S45H60.SGD","LU2413666426.HKD","LU2361045086.USD","LU0511384066.AUD","LU1069344957.HKD","MSFT","LU2756315664.SGD","LU1429558221.USD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2506436819","title":"Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure","url":"https://stock-news.laohu8.com/highlight/detail?id=2506436819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506436819?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2242650005.HKD","LU0994945656.USD","SG9999014575.USD","TVGNW","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","LU2413666426.HKD","LU0149725797.USD","LU0820561909.HKD","TVGN","LU2357305700.SGD","LU0690374961.EUR","LU2756315664.SGD","LU0511384066.AUD","IE00B3S45H60.SGD","IE00BN29S564.USD","LU0882574139.USD","LU1429558221.USD","LU0690374615.EUR","LU0069063385.USD","LU1691799644.USD","LU0187121727.USD","LU0820562030.AUD","LU1868836914.USD","LU0965509010.AUD","IE00BJTD4V19.USD","LU1839511570.USD","LU0868494617.USD","LU0081259029.USD","LU2552382132.HKD","LU1066051811.HKD","LU1823568750.SGD","LU1069344957.HKD","LU0894486033.HKD","IE00BDRTCR15.USD","LU1037948897.HKD","LU1670628061.USD","IE00B775H168.HKD","LU1629891620.HKD","LU0162691827.USD","LU1323610961.USD","IE00BJJMRX11.SGD","LU0289961442.SGD","LU1571399168.USD","LU1582986433.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU1340139317.AUD","MSFT","LU1564329115.USD"],"gpt_icon":0},{"id":"2506819048","title":"Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure","url":"https://stock-news.laohu8.com/highlight/detail?id=2506819048","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506819048?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758040,"startTime":"0","endTime":"0","summary":"This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification.Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus .Tevogen.AI, Tevogen Bio’s artificial intelligence effort, will integrate Microsoft’s advanced AI tools and the Microsoft Azure cloud platform into two key objectives:. Rapidly Expanding the ExacTcell Technology Pre-Clinical PipelineBuilding on the successful trial results of TVGN 489, Tevogen Bio aims to utilize machine learning to perform critical simulations that will accelerate the identification of new targets. By leveraging Microsoft’s AI, the company can analyze large datasets across the genome with greater speed and accuracy.By leveraging the Microsoft Azure cloud platform and a suite of advanced AI tools, Tevogen Bio is also proactively investigating potential treatments for Human Pa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bio-broadens-relationship-microsoft-223400494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014914.USD","LU0689472784.USD","LU2756315318.SGD","MSFT","LU1732800096.USD","LU1188199696.SGD","TVGNW","LU1116320901.HKD","SG9999001424.SGD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU2095319765.USD","LU2237438978.USD","LU2347655156.SGD","LU0175139822.USD","BK4503","LU0820561909.HKD","LU1116320737.USD","BK4554","LU1059921491.USD","LU1670711123.USD","LU0069063385.USD","LU0267386448.USD","IE00BJLML261.HKD","LU1815333072.USD","TVGN","LU2087621335.USD","LU1506573853.SGD","LU0265550946.USD","IE00BKDWB100.SGD","BK4534","LU2458330169.SGD","LU0683600562.USD","LU2326559502.SGD","LU0823421416.USD","LU0289739343.SGD","LU0719512351.SGD","LU1235295455.SGD","BK4516","LU0661504455.SGD","LU2213496289.HKD","LU0553294199.USD","LU1551013342.USD","IE00BBT3K403.USD","LU0949170426.SGD","IE0004086264.USD","LU2237957902.USD","IE0004445239.USD","LU0965509010.AUD","LU1037948897.HKD","IE00B7KXQ091.USD","LU2506951958.HKD"],"gpt_icon":1},{"id":"2492217318","title":"Tevogen files for additional patent on predictive AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2492217318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492217318?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:50","pubTimestamp":1734616228,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) Bio filed for an additional patent, “Systems And Methods For Predicting Immunologically Active Peptides With Machine Learning Models...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-files-for-additional-patent-on-predictive-ai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-files-for-additional-patent-on-predictive-ai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2489469783","title":"Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469783","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489469783?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:03","pubTimestamp":1733414580,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Dec. 05, 2024  -- Dr. Ryan Saadi, CEO of Tevogen Bio  , a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, congratulates Board Member, Victor Sordillo PE, CSP, MBA, as he was inducted into The New Jersey League of Municipalities Hall of Fame this month.Mayor Sordillo was inducted into the Hall of Fame for his dedicated tenure of 24 years of continuous service as a Warren Township Committee Member. As an elected official, Mayor Sordillo served the community by leading the municipal government, providing oversight to the township’s operations, and implementing policies for the public good, essentially working for the benefit of the citizens he represents.Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T ce","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Hca4JbhEpE2GIG980_m0Og--~B/aD0xMzE2O3c9ODc3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4ce4244d7a99470b7b5aca6271af6d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Hca4JbhEpE2GIG980_m0Og--~B/aD0xMzE2O3c9ODc3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4ce4244d7a99470b7b5aca6271af6d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dr-ryan-saadi-commends-individuals-160300813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2486070180","title":"Tevogen announces additional responsibilities for key leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486070180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486070180?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:15","pubTimestamp":1732626920,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) Bio announced addition responsibilities for key leaders to further expand company capabilities. As part of this leadership evolution...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-announces-additional-responsibilities-for-key-leaders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-announces-additional-responsibilities-for-key-leaders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2486407771","title":"Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2486407771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486407771?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:05","pubTimestamp":1732626300,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Nov. 26, 2024  -- Tevogen Bio  , a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced addition responsibilities for key leaders to further expand company capabilities.Tapan V Shah, Head of Investor Relations and Corporate Development, will take on added responsibility for US Government Affairs and Policy.William Keane, Vice President of Strategic Initiatives, will assume additional responsibilities for New Business Development.Wojtek Stobinski, Corporate Identity Lead, will oversee the business integration of any potential future acquisitions.Commitment to C.O.R.E. Values: Curiosity, Optimism, Respect, and Equality. Tevogen Bio’s culture, known as C.O.R.E., underpins the company’s mission and fosters a collaborative environment built on Curiosity, Optimism, Respect, and Equality. These values are more than guiding principles—they are foundational to ho","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bio-prepares-organizational-readiness-130500359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2485428845","title":"Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428845","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485428845?lang=en_us&edition=fundamental","pubTime":"2024-11-22 04:59","pubTimestamp":1732222783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA1YPKL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2485428639","title":"Press Release: Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428639","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485428639?lang=en_us&edition=fundamental","pubTime":"2024-11-22 04:59","pubTimestamp":1732222740,"startTime":"0","endTime":"0","summary":"Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value. WARREN, N.J., Nov. 21, 2024  -- Tevogen Bio  , a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today expresses gratitude to shareholders for their unwavering support and trust in Tevogen Bio and its leadership. The commitment fuels the company's determination to advance its mission of developing accessible, life-saving therapeutics.The company recently announced significant progress through its third quarter financial results for 2024, including, reduction of a net loss by $52.5 million, elimination of nearly all liabilities, and reiterating availability of sufficient capital to fund operations for the next 33 months.Tevogen is driven by a team of highly experienced industry leaders and dis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2484114228","title":"Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2484114228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484114228?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:11","pubTimestamp":1732111864,"startTime":"0","endTime":"0","summary":"US stocks look set to open higher in Wednesday's trading session as investors await Nvidia's (NVDA) earnings report and look ahead to key data coming out Thursday, including initial jobless claims, th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":[".IXIC",".DJI",".SPX","TGT","CARE","HOFV","ISBC","QSI","AVNS","NVDA","SOAR","SKYT","PKBK","TVGN","KITT"],"gpt_icon":1},{"id":"2484619607","title":"Tevogen Bio Surges Premarket After Reporting Q3 Results, 'Nearly All' Liabilities Eliminated","url":"https://stock-news.laohu8.com/highlight/detail?id=2484619607","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484619607?lang=en_us&edition=fundamental","pubTime":"2024-11-20 19:13","pubTimestamp":1732101201,"startTime":"0","endTime":"0","summary":"Tevogen Bio Surges Premarket After Reporting Q3 Results, 'Nearly All' Liabilities Eliminated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2484901480","title":"Tevogen reports Q3 EPS (3c) vs (3c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2484901480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484901480?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:55","pubTimestamp":1732053309,"startTime":"0","endTime":"0","summary":"Kirti Desai, CPA, Tevogen’s (TVGN) CFO, commented, “The company is in a unique position as it relates to reporting intangible assets on our balance...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-reports-q3-eps-3c-vs-3c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-reports-q3-eps-3c-vs-3c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2484693909","title":"Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2484693909","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484693909?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:53","pubTimestamp":1732053208,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/42076122/tevogen-bio-holdings-q3-eps-0-03-same-as-prior-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2484390961","title":"BRIEF-Tevogen Bio Reports Third Quarter 2024 Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484390961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484390961?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:52","pubTimestamp":1732053136,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Bio Reports Third Quarter 2024 Financial Nov 19 (Reuters) - Tevogen Bio Holdings Inc TVGN.O:TEVOGEN BIO REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; HIGHLIGHTS SIGNIFICANTLY IMPROVED FI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA4QZXGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2484909633","title":"Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2484909633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484909633?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:50","pubTimestamp":1732053042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA4QZXGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2484909632","title":"Press Release: Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2484909632","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484909632?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:50","pubTimestamp":1732053000,"startTime":"0","endTime":"0","summary":"Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model. -- Improved operating performance by reducing net loss by $52.5 million;reported net loss of $4.3 million and $56.8 million for the nine months. its liabilities; reported $10.5 million as of September 30, 2024, and. Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.Kirti Desai, CPA, Tevogen's CFO, commented, \"The company is in a unique position as it relates to reporting intangible assets on our balance sheet. Tevogen has multiple granted patents, which were devel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2483839531","title":"Tevogen Bio Delays Latest Quarterly Filing with SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483839531?lang=en_us&edition=fundamental","pubTime":"2024-11-16 06:26","pubTimestamp":1731709560,"startTime":"0","endTime":"0","summary":"Tevogen Bio said it is delaying the publication of its filing third-quarter filing with the Securities and Exchange Commission, citing material weaknesses in its internal controls over financial reporting.The biotechnology company on Friday said the delay follows a recent change in the third party firm in charge of a portion of its internal accounting and financing reporting.Overall for the third quarter, the company expects to post a loss of about $4.3 million for the first nine months of 2024, down from a loss of $56.8 million for the same period a year earlier.The news come a day after founder and Chief Executive Ryan Saadi suggested the company needed to raise capital.\"Founders must navigate the need for capital to fuel growth with a vigilant eye on avoiding equity dilution,\" Saadi said. \"Our financing options must consider preserving shareholder value and the potential equity dilution of warrant conversion at a strike price of $11.50 per share.\"","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2483337963","title":"Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2483337963","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483337963?lang=en_us&edition=fundamental","pubTime":"2024-11-15 04:49","pubTimestamp":1731617340,"startTime":"0","endTime":"0","summary":"Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a fraction of the industry norm.In his conversation with the leadership team, Dr. Saadi shared, “Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a fraction of the industry norm. Tevogen’s success would not be possible without its passionate team united by a common vision.” He added, “Founders must navigate the need for capital to fuel growth with a vigilant eye on avoiding equity dilution. Our financing options must consider preserving shareholder value and the potential equity dilution of warrant conversion at a strike price of $11.50 per share.”Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-founder-reflects-importance-preserving-204900794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2025-04-25","current":-13.530067,"percent":0.656934,"low":-87.683882,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"high":-2.106753,"avg":-23.042099,"sd":16.228005,"marketCap":185732367},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367}],"updateTime":1745689271925}}}